Filtered By:
Condition: Diabetes
Countries: Canada Health
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 188 results found since Jan 2013.
Exercise medicine and physical activity promotion: core curricula for US medical schools, residencies and sports medicine fellowships: developed by the American Medical Society for Sports Medicine and endorsed by the Canadian Academy of Sport and Exercise Medicine
Br J Sports Med. 2022 Jan 10:bjsports-2021-104819. doi: 10.1136/bjsports-2021-104819. Online ahead of print.ABSTRACTRegular physical activity provides a variety of health benefits and is proven to treat and prevent several non-communicable diseases. Specifically, physical activity enhances muscular and osseous strength, improves cardiorespiratory fitness, and reduces the risk of hypertension, coronary heart disease, stroke, type 2 diabetes, mental health disorders, cognitive decline and several cancers. Despite these well-known benefits, physical activity promotion in clinical practice is underused due to insufficient trai...
Source: British Journal of Sports Medicine - January 11, 2022 Category: Sports Medicine Authors: Irfan Asif Jane S Thornton Stephen Carek Christopher Miles Melissa Nayak Melissa Novak Mark Stovak Jason L Zaremski Jonathan Drezner Source Type: research
Prognosis and Clinical Results after Coronary Artery Bypass Operation in Young Patients Aged < 45 Years: Chances and Limitations of a New Therapy Option
Thorac Cardiovasc Surg DOI: 10.1055/s-0041-1736229Coronary artery bypass grafting (CABG) is the recommended type of revascularization procedure in patients with left main or three-vessel disease and is considered an alternative when percutaneous coronary intervention is not feasible. We evaluated registry data to obtain long-term outcome data.All patients ≤45 years in whom CABG was performed between 2009 and 2019 were selected from the Heart and Diabetes Center NRW, Germany. Cox regression analysis was applied to estimate the incidence risk of events after surgery.A total of 209 patients (81.8% male) were included. Mean ...
Source: The Thoracic and Cardiovascular Surgeon - November 22, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Wittlinger, Thomas Schramm, Ren é Bleiziffer, Sabine Rudolph, Volker Gummert, Jan Fritz Deutsch, Marcus-Andr é Tags: Original Cardiovascular Source Type: research
Socioeconomic disparities in the prevalence of comorbid chronic conditions among Canadian adults with cancer
CONCLUSION: History of cancer is associated with a higher probability of many comorbid conditions. This excess comorbidity burden seems to be unequally shouldered by individuals in the lower socioeconomic stratum as well as minority populations.PMID:34726566 | DOI:10.1080/0284186X.2021.1995892
Source: Acta Oncologica - November 2, 2021 Category: Cancer & Oncology Authors: Omar Abdel-Rahman Scott North Source Type: research
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Percutaneous coronary intervention of totally occluded coronary venous bypass grafts: An exercise in futility?
CONCLUSION: PCI of totally occluded SVG can be performed with a high procedural success rate. However, its clinical utility remains limited by poor follow-up outcomes.PMID:34621494 | PMC:PMC8462047 | DOI:10.4330/wjc.v13.i9.493
Source: World Journal of Cardiology - October 8, 2021 Category: Cardiology Authors: Evan W Nardone Brandon M Madsen Melissa M McCarey David L Fischman Nicholas J Ruggiero Paul Walinsky Alec Vishnevsky Michael P Savage Source Type: research
